Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3971411 | 0.91 | DPP4 (0.56) | DPP4FAP | |
| SCHEMBL3966118 | 0.87 | DPP4 (0.51) | DPP4FAP | |
| SCHEMBL3971487 | 0.86 | DPP4 (0.58) | DPP4FAP | |
| SCHEMBL4082595 | 0.85 | DPP4 (0.53) | DPP4FAP | |
| SCHEMBL3967659 | 0.85 | DPP4 (0.60) | DPP4FAP | |
| SCHEMBL3969500 | 0.85 | DPP4 (0.54) | DPP4FAP | |
| SCHEMBL3967148 | 0.85 | DPP4 (0.54) | DPP4FAP | |
| SCHEMBL3970558 | 0.85 | DPP4 (0.52) | DPP4FAP | |
| SCHEMBL3970033 | 0.84 | DPP4 (0.58) | DPP4FAP | |
| SCHEMBL3966257 | 0.84 | DPP4 (0.65) | DPP4FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7569574-B2 | Purine derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2009-08-04 | — | — | US | disclosed |
| EP-1532150-B1 | NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA (DE) | 2008-06-11 | — | — | EP | disclosed |
| EP-1532150-A1 | NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2005-05-25 | — | — | EP | disclosed |
| WO-2004018469-A1 | NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-03-04 | — | — | WO | disclosed |